HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.

Vitkevičienė A, Skiauterytė G, Žučenka A, Stoškus M, Gineikienė E, Borutinskaitė V, Griškevičius L, Navakauskienė R

DOI: 10.1155/2019/6179573
Published: 2019
Container: Journal of oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2019/6179573,
  title = {HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.},
  author = {Vitkevičienė A and Skiauterytė G and Žučenka A and Stoškus M and Gineikienė E and Borutinskaitė V and Griškevičius L and Navakauskienė R},
  year = {2019},
  journal = {Journal of oncology},
  doi = {10.1155/2019/6179573},
  url = {https://doi.org/10.1155/2019/6179573}
}

RIS

TY  - JOUR
TI  - HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.
AU  - Vitkevičienė A
AU  - Skiauterytė G
AU  - Žučenka A
AU  - Stoškus M
AU  - Gineikienė E
AU  - Borutinskaitė V
AU  - Griškevičius L
AU  - Navakauskienė R
PY  - 2019
JO  - Journal of oncology
DO  - 10.1155/2019/6179573
UR  - https://doi.org/10.1155/2019/6179573
ER  -

APA

A, V., G, S., A, Ž., M, S., E, G., V, B., L, G., & R, N. (2019). HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.. Journal of oncology. https://doi.org/10.1155/2019/6179573

Source records

pubmed · retrieved 2026-09-27T10:44:48.156Z